KINGSTON, Jamaica — The United Kingdom (UK) and Jamaica have strengthened their partnership in healthcare and regulatory cooperation following Jamaica’s recent participation in the UK-Caribbean Healthcare Mission.

The mission is a landmark regional initiative aimed at building more resilient and effective healthcare systems across the Caribbean, according to a press release from the UK High Commission in Jamaica.

It brought together representatives from the UK, Jamaica, and several other Caribbean countries namely Trinidad and Tobago, Barbados, Guyana and St Lucia, for high-level engagement, knowledge exchange and collaboration focused on strengthening healthcare delivery, regulatory standards, and innovation across the region.

Commenting on the mission, British High Commissioner to Jamaica, Alicia Herbert, said: “The UK-Caribbean Healthcare Mission brought together the UK, Jamaica, and partners from across the region with one shared goal – to strengthen healthcare systems and build resilience for the future. It was the first initiative of its kind. By sharing the UK’s expertise in life sciences, medical technology and regulation, the mission created a platform for a strong UK-Jamaica partnership to tackle common health priorities.”

Over the course of the mission, participants engaged in substantive discussions on the UK’s internationally recognised healthcare and pharmaceutical regulatory framework, with a focus on practical approaches to improving healthcare systems in the Caribbean. Key areas of engagement included: streamlining drug registration processes; digital integration within regulatory systems; strengthening safety, compliance, and quality assurance; addressing illegal and parallel pharmaceutical imports; and aligning with international standards and best practices.

The programme also explored cross-sector collaboration, professional development, and the application of regulatory equivalence to support more efficient access to safe and effective medicines.

Participants benefited from in-depth engagements with leading UK institutions, including the Medicines and Healthcare products Regulatory Agency (MHRA), King’s College London, the National Institute for Health and Care Excellence (NICE), the Association of the British Pharmaceutical Industry (ABPI) and the Centre for Innovation in Regulatory Science (CIRS). These sessions provided valuable insights into governance models, health technology assessment, and global regulatory benchmarks relevant to Jamaica’s healthcare priorities.

The mission reinforced the UK’s commitment to supporting Jamaica’s healthcare development through collaboration, innovation and knowledge-sharing, and forms part of the UK’s broader engagement across health, development, and regulatory cooperation in the Caribbean.

The UK looks forward to building on the outcomes of the mission and continuing to work closely with Jamaica and other partners to strengthen healthcare systems that deliver better outcomes for communities across Jamaica and the wider Caribbean region.